Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 72789-391

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 72789-391). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789391 Label (72789391)

Label for Esomeprazole Magnesium DR USP 40 mg delayed-release capsules, containing 90 capsules per package. The label includes the drug name, strength, dosage form, quantity, and manufacturer details for PD-Rx Pharmaceuticals, Inc. The NDC number is 72789-391-90, with lot and expiration dates visible. The label advises to not crush or chew the capsules and includes a warning to keep out of reach of children.*

FDA Label Image

Figure1 (Figure1)

Chemical structure diagram of esomeprazole magnesium, showing the molecular components including aromatic rings, nitrogen, sulfur, oxygen atoms, and magnesium ion complexed with water molecules.*

FDA Label Image

Figure2 (Figure2)

A line graph showing the percentage of subjects maintaining a certain condition over six months. Four groups are compared: Esomeprazole 40 mg, 20 mg, 10 mg, and placebo. The y-axis shows percent maintained from 0 to 100%, and the x-axis shows time in months from 0 to 6. Lines indicate that higher doses of Esomeprazole have higher percentages maintained compared to placebo over time.*

FDA Label Image

Figure3 (Figure3)

A line graph depicting the percentage of maintained effect over six months for Esomeprazole Magnesium oral delayed-release capsules at 40 mg, 20 mg, and 10 mg doses compared to placebo. The y-axis represents percent maintained, while the x-axis represents time in months. Data shows higher maintenance percentages for the 40 mg and 20 mg doses.*

FDA Label Image

Figure4 (Figure4)

A line graph comparing the percent of patients symptom-free over a 28-day diary period for three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The x-axis represents diary days from 0 to 28, and the y-axis represents the percent of patients symptom-free, ranging from 0 to 100 percent.*

FDA Label Image

Figure5 (Figure5)

A line graph comparing the percent of patients symptom-free over 28 days, with separate lines for Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The x-axis represents diary days from 0 to 28, and the y-axis represents the percent of patients symptom-free from 0% to 100%. The graph shows increasing symptom relief over time for both Esomeprazole doses compared to placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.